InvestorsHub Logo
Post# of 180732
Next 10
Followers 44
Posts 2409
Boards Moderated 0
Alias Born 10/20/2008

Re: None

Monday, 08/24/2015 10:28:30 PM

Monday, August 24, 2015 10:28:30 PM

Post# of 180732
Interesting stock. But historical chart looks terrible. Cancer treatment plays are littered with failure. FDA APPROVAL AND CLINICAL TRIALS PROCESS IS extremely EXPENSIVE AND LENGTHY. Well funded pharma companies face enormous failure rates for potential new therapies and drug approvals. What makes this any different? No emotional rants please. TIA

Everything I say,is only my opinion. DO not rely on anything I post,as buy or sell advice. DO your own homework.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News